[HTML][HTML] Promising antiviral activities of natural flavonoids against SARS-CoV-2 targets: systematic review
The ongoing COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) became a globally leading public health concern over the past …
coronavirus 2 (SARS-CoV-2) became a globally leading public health concern over the past …
[HTML][HTML] Therapeutic potentials of antiviral plants used in traditional african medicine with COVID-19 in focus: a Nigerian perspective
The coronavirus disease 2019 (COVID-19) pandemic is caused by an infectious novel strain
of coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
of coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Correlates of COVID-19 vaccination intentions: Attitudes, institutional trust, fear, conspiracy beliefs, and vaccine skepticism
Successful campaigns to combat the COVID-19 pandemic depend, in part, on people's
willingness to be vaccinated. It is therefore critical to understand the factors that determine …
willingness to be vaccinated. It is therefore critical to understand the factors that determine …
[HTML][HTML] SARS-CoV-2 spike targets USP33-IRF9 axis via exosomal miR-148a to activate human microglia
R Mishra, AC Banerjea - Frontiers in immunology, 2021 - frontiersin.org
SARS-CoV-2, the novel coronavirus infection has consistently shown an association with
neurological anomalies in patients, in addition to its usual respiratory distress syndrome …
neurological anomalies in patients, in addition to its usual respiratory distress syndrome …
[HTML][HTML] A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle
The advent and persistence of the Severe Acute Respiratory Syndrome Coronavirus–2
(SARS-CoV-2)-induced Coronavirus Disease (COVID-19) pandemic since December 2019 …
(SARS-CoV-2)-induced Coronavirus Disease (COVID-19) pandemic since December 2019 …
[HTML][HTML] Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
L Chitsike, P Duerksen-Hughes - Virology Journal, 2021 - Springer
The COVID-19 pandemic has put healthcare infrastructures and our social and economic
lives under unprecedented strain. Effective solutions are needed to end the pandemic while …
lives under unprecedented strain. Effective solutions are needed to end the pandemic while …
In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions
Abstract Coronavirus disease-2019 (COVID-19), a global pandemic, has currently infected
more than 247 million people around the world. Nowadays, several receptors of COVID-19 …
more than 247 million people around the world. Nowadays, several receptors of COVID-19 …
[HTML][HTML] Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral …
S Homaeigohar, X Liu, M Elbahri - Journal of Controlled Release, 2023 - Elsevier
Antiviral peptides and antiviral polysaccharides can play a major role in the prevention and
treatment of emerging viral health problems. These antiviral compounds are biocompatible …
treatment of emerging viral health problems. These antiviral compounds are biocompatible …
In silico Studies on the Interaction between Mpro and PLpro From SARS‐CoV‐2 and Ebselen, its Metabolites and Derivatives
The COVID‐19 pandemic caused by the SARS‐CoV‐2 has mobilized scientific attention in
search of a treatment. The cysteine‐proteases, main protease (Mpro) and papain‐like …
search of a treatment. The cysteine‐proteases, main protease (Mpro) and papain‐like …
[HTML][HTML] Elucidating interactions between SARS-CoV-2 trimeric spike protein and ACE2 using homology modeling and molecular dynamics simulations
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). As of October 21, 2020, more than 41.4 million confirmed cases …
disease 2019 (COVID-19). As of October 21, 2020, more than 41.4 million confirmed cases …